Gene · 9113
Papers3,081
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 3,081
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Jub-induced phosphorylation of Warts inhibits its activity and recruitment into biomolecular condensates. | Cell Rep | 2025 | 41351836 | PubTator, text mining | PubMed |
| FAM189A2 activates Hippo signaling pathway by abrogating WWP2-mediated LATS1 ubiquitination, to inhibit the glycolysis and proliferation processes of lung adenocarcinoma. | J Transl Med | 2025 | 41350729 | PubTator, text mining | PubMed |
| Quercetin alleviates rifampicin-induced hepatocyte injury by modulating the Hippo-YAP signaling pathway. | Front Med (Lausanne) | 2025 | 41341816 | PubTator, text mining | PubMed |
| KSR1 is a scaffold for the Hippo signaling pathway. | Commun Biol | 2025 | 41326667 | PubTator, text mining | PubMed |
| Investigating the role of transforming growth factor-beta/transforming growth factor-beta receptor in the development of hepatocellular carcinoma through the Salvador-Warts-Hippo pathway. | Int J Mol Cell Med | 2025 | 41321971 | PubTator, text mining | PubMed |
| Glutamine synthetase modulates YAP activation by stabilizing LATS under glutamine homeostasis. | Cell Rep | 2025 | 41296569 | PubTator, text mining | PubMed |
| STUPPIT is a proximity labeling tool for labeling intermediary proteins that bridge two non-interacting proteins. | PLoS Biol | 2025 | 41284752 | PubTator, text mining | PubMed |
| Loss of CFIm activates YAP/TAZ and connects mRNA cleavage and polyadenylation inhibition to BRCAness. | bioRxiv | 2025 | 41278918 | PubTator, text mining | PubMed |
| Machine learning analysis facilitates the identification of liver biomarkers in postmortem diagnosis of heat stroke. | Leg Med (Tokyo) | 2025 | 41172582 | PubTator, text mining | PubMed |
| Casein kinase 1 family member CSNK1E can regulate proliferation and migration in hepatocellular carcinoma. | J Cancer Res Clin Oncol | 2025 | 41014359 | PubTator, text mining | PubMed |
| NCAPH-YAP1 interaction promotes breast cancer stemness and tumor progression. | Stem Cell Res Ther | 2025 | 40999529 | PubTator, text mining | PubMed |
| The reduced DLG5 promotes doxorubicin resistance in breast cancer cells MCF-7 through regulating autophagy. | Discov Oncol | 2025 | 40993338 | PubTator, text mining | PubMed |
| Targeting developmental vulnerabilities in childhood sarcomas. | Cancer Metastasis Rev | 2025 | 40983796 | PubTator, text mining | PubMed |
| iPSC-based drug discovery identified the Hippo signaling pathway as a therapeutic target in the fibrosis of NPHP1-deficient nephronophthisis. | Stem Cell Res Ther | 2025 | 40968381 | PubTator, text mining | PubMed |
| STK4 inhibits the E3 activity of HOIP by phosphorylating its allosteric ubiquitin-binding site. | Cell Discov | 2025 | 40957900 | PubTator, text mining | PubMed |
| Correction: Liquid-liquid phase separation of GPS2-LATS1 promotes colorectal cancer progression by reprogramming lipid metabolism. | Oncogene | 2025 | 40931052 | PubTator, text mining | PubMed |
| Histone Methyltransferase EHMT2 Promotes the Progression of Breast Ductal Carcinoma by Regulating the Hippo Pathway. | J Environ Pathol Toxicol Oncol | 2025 | 40921139 | PubTator, text mining | PubMed |
| Caenorhabditis elegans Uses Canonical and Non-canonical Hippo signaling. | bioRxiv | 2025 | 40909657 | PubTator, text mining | PubMed |
| Regulation of tension-dependent localization of LATS1 and LATS2 to adherens junctions. | bioRxiv | 2025 | 40909571 | PubTator, text mining | PubMed |
| Bladder Cancer: Role of Circular RNAs in Oncogenesis, Tumor Suppression, and Therapeutic Target Identification. | Cancer Genomics Proteomics | 2025 | 40883021 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/9113/papers?page=5